Stark DME hearing
This article was originally published in The Gray Sheet
Executive Summary
Rep. Pete Stark (D-Calif.), chairman of the House Ways and Means health subcommittee, plans April 14 hearing to address "issues relating to clinical laboratory services and durable medical equipment," according to a March 26 press release. The subcommittee points out that the Congressional Budget Office has estimated that President Clinton's fiscal year 1994 budget proposal ("The Gray Sheet" Feb. 22, p. 1) includes provisions that would reduce payments for DME by $651 mil. over five years. Stark recently introduced legislation (H.R. 1255) aimed at preventing DME-related fraud and abuse.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.